BCom CA MAICD
Mr Mitchell has extensive international healthcare and finance experience. Mr Mitchell is a qualified Chartered Accountant with 27 years’ experience (until March 2017) as Chief Financial Officer and Company Secretary of ASX-listed Cochlear Limited, a world leading medical device developer, manufacturer and seller.
Mr Mitchell currently holds non-executive director roles with ASX-listed healthcare companies, Fisher & Paykel Healthcare (since November 2018), Sonic Healthcare (since September 2017), Osprey Medical Inc. (since July 2012). He is also a member of the Australian Board of Taxation and a director of South East Sydney Local Health District.
He has previously performed roles with a number of industry and government committees, including Chairman of the Group of 100 (Australia’s peak body for senior finance executives) and Chairman of the Standing Committee (Accounting and Audit) for the Australian Securities and Investments Commission (ASIC) and he was a member of the NSW Government’s Medical Device Fund.
Mr Mitchell was appointed as a director of QBiotics Group on 1 November 2017.